Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients, as well as provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
-0.28EPS Dil.
-0.15P/E
9.44MMarket Cap
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2018
2019
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Revenue per ShareRevenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Basic EPS, GAAPBasic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Free Cash Flow per Basic ShareFree Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Dividend per ShareDividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Book Value per ShareBook Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Tangible Book Value per ShareTangible Book Value per Share